Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Pharma
Why so many people overuse antibiotics
Life Sciences Times
-
January 28, 2021
0
Biotech
Waters Otto SPEcialist Positive Pressure Manifold Improves Reproducibility and Reliability of Solid-Phase Extraction
Life Sciences Times
-
January 27, 2021
0
Public Health
As Patient Concerns Linger Over Possible COVID-19 Vaccine Risks, US Healthcare Professionals Believe 80% Will Get the Flu Vaccine this Year
Life Sciences Times
-
January 27, 2021
0
Public Health
PerkinElmer Launches Industry-Leading Solus One E. coli O157 Pathogen Detection Assay for Beef & Beef Trim Testing
Life Sciences Times
-
January 27, 2021
0
Real Estate
Top Life Sciences Clusters to See 36 Million Square Feet of New Construction Delivery
Life Sciences Times
-
January 27, 2021
0
Public Health
Global Covid-19 cases surpass 100mn: Johns Hopkins University
Life Sciences Times
-
January 27, 2021
0
Pharma
200 million extra doses: Biden-led Covid-19 turnaround kicks off
Life Sciences Times
-
January 27, 2021
0
Medtech
Samsung health tracking app soon in 31 more countries
Life Sciences Times
-
January 27, 2021
0
Biotech
This immune cell in blood may up severe Covid risk
Life Sciences Times
-
January 27, 2021
0
Biotech
Bharat Biotech to make antigen for first-ever anti-malaria vaccine
Life Sciences Times
-
January 27, 2021
0
1
...
787
788
789
...
805
Page 788 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026